Tag Archives: TB drug price slashed in global push to thwart killer disease

A pharmaceutical multinational on Thursday slashed the price of a key anti-tuberculosis drug boosting the battle against the world’s deadliest infectious disease, as a new treatment was also set to begin extensive testing. The initiatives came as the United Nations seeks to galvanise the campaign against TB, which killed 1.5 million people worldwide last year and saw 10 million more …

Read More »